Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New frizzled SMO receptor antagonist SEN-450 inhibits tumor growth in vivo

May 4, 2011

Centocor Ortho Biotech withdraws NDA for Yondelis in recurrent ovarian cancer

May 3, 2011

Bayer claims new hepatocyte growth factor receptor inhibitors

May 3, 2011

New vitamin D receptor ligands disclosed

May 3, 2011

GBR-500 slows growth of prostate tumors in vivo

May 3, 2011

FDA grants orphan drug status to CytRx's INNO-206 in pancreatic cancer

May 2, 2011

FDA approves Fusilev in combination with 5-FU for colorectal cancer

May 2, 2011

Vandetanib launched in U.S. for advanced medullary thyroid cancer

May 2, 2011

First selective ganglioside biosynthesis inhibitors identified at Zacharon Pharma

May 2, 2011

New lysophospholipid receptor antagonists reported by Amira Pharma

May 2, 2011

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...